Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
The monitoring of key risk indicators (KRIs) is an established form of risk control in the...
Source: Applied Clinical Trials
- Press Release
King of Prussia, PA – April 1st, 2025: CluePoints, provider of leading statistical and AI-driven software...
- Featured Article
Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM)...
Source: The Clinical Trial Vanguard
- Press Release
The Company, along with its Research and Development Teams, were shortlisted for continuing its mission of...
- Featured Article
The pharmaceutical industry is poised for a transformative evolution by 2025, driven by the possibilities of...
Source: PM360
- Featured Article
Central monitoring is highly effective in detecting emerging quality issues in clinical trials, but debate continues...
Source: Applied Clinical Trials
- Featured Article
An essential component of risk-based quality management (RBQM), as detailed in both the ICH E8 (R1)...
Source: Applied Clinical Trials
- Press Release
CluePoints Appoints Richard Young as Chief Strategy Officer King of Prussia, PA – October 28th, 2024:...
- Press Release
King of Prussia, PA – October 23rd, 2024: CluePoints, provider of leading statistical and AI-driven software...
- Featured Article
The need to boost education, shift culture, and embrace new technologies.
...Source: Applied Clinical Trials
- Press Release
CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest...
- Featured Article
As an industry, we regularly discuss the benefits of adopting risk-based quality management (RBQM). The good...
Source: International Clinical Trials/European Pharmaceutical Contractors
- Press Release
“I KNOW ICH E6 (R2) COMPLIANCE INSISTS ON A RISK-BASED APPROACH TO RUNNING MY TRIALS, BUT...
- Press Release
Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational...
- Press Release
WAYNE, PA – April 09, 2019: CluePoints, a leading provider of Risk-Based Study Execution(RBx) and Data...
- Press Release
We’re delighted to announce that registration for CluePoints’ US Risk-Based Quality Management Roadshow is now open....
- Press Release
Are you struggling with how to assess the true value of improving data quality and integrity...
- Press Release
The other week, CluePoints in conjunction with HighPoint Solutions delivered 3 European Roadshows in Basel, Copenhagen...
- Press Release
Wayne, PA – October 02, 2018: CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data...
- Press Release
Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints to...
- Press Release
Since the initial publication of the ICH GCP guidelines, the way clinical trials operate has changed...
- Press Release
It appears that 2018 is the year CluePoints really established itself as a leader in the...
- Press Release
Successful pilot project prompts strategic partnership that strengthens risk-based monitoring in Japan and places both companies...
- Press Release
Wayne, PA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Featured Article
An expectation for the use of quality tolerance limits (QTLs) was formally established in the International...
Source: Applied Clinical Trials
- Featured Article
Clinical research is evolving rapidly, with the digitalization of trials creating a new modus operandi and...
Source: Applied Clinical Trials
- Featured Article
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published...
Source: Applied Clinical Trials
- Featured Article
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Source: Applied Clinical Trials
- Featured Article
The success of clinical development programmes, drug approval and marketing depends ultimately on the readability and...
Source: International Clinical Trials
- Featured Article
Central monitoring, which typically includes the use of key risk indicators (KRIs), aims at improving the...
Source: Springer Link
- Featured Article
Clinical research is in the grips of a revolution that has caused a wave of new...
Source: ACRP
- Featured Article
Virtual or decentralized clinical trials present a far more patient-centric approach to conducting clinical research, building...
Source: Applied Clinical Trials
- Featured Article
A central statistical assessment of the quality of data collected in clinical trials can improve the...
Source: National Library of Medicine
- Featured Article
Risk-Based Quality Management (RBQM) and Risk-Based Monitoring (RBM) are shifting the clinical research landscape, dramatically accelerating...
Source: Applied Clinical Trials
- Featured Article
By empowering researchers to detect data quality issues in real-time, Risk-Based Quality Management (RBQM) and Risk-Based...
Source: Journal for Clinical Studies
- Featured Article
Amid the ongoing Coronavirus pandemic, clinical trial sites are increasingly inaccessible for patients and site staff,...
Source: Tufts Center for the Study of Drug Development
